US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractyl Health

1.37

+0.150012.30%

Post-market: 1.370.00000.00%17:23 EDT

Volume:411.77K

Turnover:545.01K

Market Cap:67.02M

PE:-0.85

High:1.39

Open:1.23

Low:1.22

Close:1.22

Loading ...

Overview Company News Filings

Fractyl Health Initiated at Buy by Canaccord Genuity

Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025

Fractyl Health Shares up 1.7% on Early-Stage Data From Weight Management Device Study

THOMSON REUTERS

BUZZ-Fractyl Health gains on early data from weight management device trial

Fractyl Health Inc - Midpoint Analysis of Remain-1 Pivotal Study Expected in Q3 2025

THOMSON REUTERS

Fractyl Health Inc - Additional Reveal-1 Patient Follow-up Data Expected in Q2 2025

THOMSON REUTERS

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After Glp-1 Discontinuation

THOMSON REUTERS

Fractyl Health Inc - No Safety or Tolerability Concerns Reported in 15 Patients Treated

THOMSON REUTERS

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation

Fractyl Health’s Earnings Call: Progress Amid Challenges

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

Simply Wall St.

Fractyl Health Reports 2024 Financial Results and Strategic Progress

BRIEF-Fractyl Health Inc Files For Mixed Shelf Offering Of Up To $300 Million

Fractyl Health files $300M mixed securities shelf

Fractyl Health Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

THOMSON REUTERS

Fractyl Health reports Q4 EPS (52c), consensus (44c)

Fractyl Health Q4 GAAP EPS $(0.52) Misses $(0.34) Estimate, Sales $3.00K Miss $10.00K Estimate

Fractyl Health Inc: Q4 EPS -$0.52

THOMSON REUTERS

Press Release: Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GUTS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GUTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GUTS\",,,,,undefined,":{"symbol":"GUTS","market":"US","secType":"STK","nameCN":"Fractyl Health","latestPrice":1.37,"timestamp":1745265600000,"preClose":1.22,"halted":0,"volume":411769,"hourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.37,"latestTime":"17:23 EDT","volume":1401,"amount":1912.2240594000002,"timestamp":1745270623325},"delay":0,"floatShares":18120861,"shares":48920221,"eps":-1.617559,"marketStatus":"Post-Mkt","change":0.15,"latestTime":"04-21 18:20:28 EDT","open":1.23,"high":1.39,"low":1.2201,"amount":545006.1247525,"amplitude":0.139262,"askPrice":1.45,"askSize":2294,"bidPrice":1.22,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.617559,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"listingDate":1706850000000,"exchange":"NASDAQ","adjPreClose":1.22,"preHourTrading":{"tag":"盘前","latestPrice":1.2789,"preClose":1.22,"latestTime":"09:28 EDT","volume":1204,"amount":1463.8360828,"timestamp":1745242121968},"postHourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.37,"latestTime":"17:23 EDT","volume":1401,"amount":1912.2240594000002,"timestamp":1745270623325},"volumeRatio":1.366238},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GUTS\",,,,,undefined,":{"symbol":"GUTS","floatShares":18120861,"roa":"-63.44%","roe":"-286.16%","lyrEps":-1.617559,"volumeRatio":1.366238,"shares":48920221,"dividePrice":0,"high":1.39,"amplitude":0.139262,"preClose":1.22,"low":1.2201,"week52Low":0.873,"pbRate":"2.36","psRate":"720.65","week52High":7.89,"institutionHeld":0,"latestPrice":1.37,"committee":-0.957338,"eps":-1.617559,"divideRate":0,"volume":411769,"delay":0,"ttmEps":-1.617559,"open":1.23,"prevYearClose":2.06,"prevWeekClose":1.22,"prevMonthClose":1.19,"prevQuarterClose":1.19,"fiveDayClose":1.01,"twentyDayClose":1.25,"sixtyDayClose":2.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GUTS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527415085","title":"Fractyl Health Initiated at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2527415085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527415085?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:41","pubTimestamp":1744720860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GUTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 15, 2025 08:41 ET (12:41 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524329443","title":"Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524329443","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524329443?lang=en_us&edition=fundamental","pubTime":"2025-04-03 03:34","pubTimestamp":1743622489,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where Fractyl Health, Inc.  stands against other micro-cap stocks insiders were buying in Q1 2025.The White House announced Tuesday that Trump’s tariffs would take effect immediately after being unveiled on Wednesday. In anticipation of these “reciprocal tariffs,” which will apply to all countries, the stock market reacted. By Tuesday morning, the broader market index and Nasdaq Composite dropped by about 0.2%, while blue-chip companies lost 0.06%.Amid ongoing market uncertainty, insider trading often comes under the spotlight. Executive stock purchases can signal optimism, but sales may reflect personal financial decisions or a need to diversify investments. To maintain transparency, executives typically follow pre-arranged strategies, like 10b5-1 plans. While insider trading can offer valuable information, it’s important to evaluate it in the broader co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fractyl-health-inc-guts-insider-193449444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524146031","title":"Fractyl Health Shares up 1.7% on Early-Stage Data From Weight Management Device Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524146031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524146031?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:33","pubTimestamp":1743514404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF13A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524187411","title":"BUZZ-Fractyl Health gains on early data from weight management device trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524187411","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524187411?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:17","pubTimestamp":1743509878,"startTime":"0","endTime":"0","summary":"BUZZ-Fractyl Health gains on early data from weight management device trial** Shares of drug developer Fractyl Health GUTS.O rise 6.7% to $1.27 premarket  ** Co says early-stage data shows its weight management device Revita helps maintain weight in patients after they discontinued taking weight-loss drugs ** One month post-procedure, seven patients experienced an average weight regain of just 1.2%, compared with the ~3% typically observed at this time period after GLP-1 discontinuation based on prior clinical studies - GUTS      ** Co expects to announce additional data from the study during Q3 of this year **  Shares of the company have fallen 42.2% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL6N3QF0L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524948851","title":"Fractyl Health Inc - Midpoint Analysis of Remain-1 Pivotal Study Expected in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524948851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524948851?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524194886","title":"Fractyl Health Inc - Additional Reveal-1 Patient Follow-up Data Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524194886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524194886?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524191092","title":"Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After Glp-1 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2524191092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524191092?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524001191","title":"Fractyl Health Inc - No Safety or Tolerability Concerns Reported in 15 Patients Treated","url":"https://stock-news.laohu8.com/highlight/detail?id=2524001191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524001191?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524019416","title":"Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2524019416","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524019416?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuation REMAIN-1 pivotal study now more than 50% enrolled; midpoint data analysis anticipated in Q3 2025 BURLINGTO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053157/0/en/Fractyl-Health-Reports-Positive-Early-Data-Showing-Revita-Has-Potential-to-Prevent-Weight-Regain-After-GLP-1-Discontinuation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","IDE","BK4082","BK4144","BK4590","GUTS"],"gpt_icon":0},{"id":"2517936192","title":"Fractyl Health’s Earnings Call: Progress Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2517936192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517936192?lang=en_us&edition=fundamental","pubTime":"2025-03-05 08:23","pubTimestamp":1741134237,"startTime":"0","endTime":"0","summary":"Fractyl Health, Inc. (($GUTS)) has held its Q4 earnings call. Read on for the main highlights of the call. Fractyl Health’s recent earnings call pa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fractyl-healths-earnings-call-progress-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fractyl-healths-earnings-call-progress-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GUTS","PRGS"],"gpt_icon":0},{"id":"2517060481","title":"Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2517060481","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517060481?lang=en_us&edition=fundamental","pubTime":"2025-03-05 01:05","pubTimestamp":1741107908,"startTime":"0","endTime":"0","summary":"As the U.S. stock market grapples with the impact of new tariffs and economic uncertainties, investors are increasingly looking for opportunities beyond well-known names. Penny stocks, a term that might seem outdated, still hold relevance as they often represent smaller or newer companies with potential for growth at lower price points. In this article, we explore three intriguing penny stocks that stand out for their financial strength and offer promising opportunities for those seeking under-the-radar investments.Overview: Fractyl Health, Inc. is a metabolic therapeutics company focused on developing treatments for type 2 diabetes and obesity, with a market cap of $75.03 million.Overview: Quince Therapeutics, Inc. is a biopharmaceutical company dedicated to acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases, with a market cap of $63.80 million.Operations: Quince Therapeutics, Inc. has not reported any revenue segments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spotlight-fractyl-health-two-other-170508449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TTI","BK4021","BK4110","BK4023","BK4509","SB","GPMT","GUTS","BABB","QNCX","BK4213","BK4209","BK4505","BK4563","BK4082","PVL","BK4526","PHX","BK4179"],"gpt_icon":1},{"id":"2516616280","title":"Fractyl Health Reports 2024 Financial Results and Strategic Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2516616280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516616280?lang=en_us&edition=fundamental","pubTime":"2025-03-04 12:03","pubTimestamp":1741061007,"startTime":"0","endTime":"0","summary":"Fractyl Health, Inc. ( ($GUTS) ) has released its Q4 earnings. Here is a breakdown of the information Fractyl Health, Inc. presented to its investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fractyl-health-reports-2024-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fractyl-health-reports-2024-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","PRGS","BK4082","GUTS","LU2065732104.USD"],"gpt_icon":0},{"id":"2516662504","title":"BRIEF-Fractyl Health Inc Files For Mixed Shelf Offering Of Up To $300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2516662504","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516662504?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:46","pubTimestamp":1741041967,"startTime":"0","endTime":"0","summary":"BRIEF-Fractyl Health Inc Files For Mixed Shelf Offering Of Up To $300 MillionMarch 3 (Reuters) - Fractyl Health Inc GUTS.O:FRACTYL HEALTH INC: FILES FOR MIXED SHELF OFFERING OF UP TO $300 MILLION - SEC FILINGFurther company coverage: GUTS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2516625226","title":"Fractyl Health files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625226","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516625226?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:30","pubTimestamp":1741041043,"startTime":"0","endTime":"0","summary":"17:26 EST Fractyl Health (GUTS) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fractyl-health-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fractyl-health-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2516646586","title":"Fractyl Health Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2516646586","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516646586?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:27","pubTimestamp":1741040828,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2516661983","title":"Fractyl Health reports Q4 EPS (52c), consensus (44c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661983","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661983?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:50","pubTimestamp":1741038641,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $3,000, consensus $10,000. “The future of obesity care isn’t just about losing weight-it’s about keeping it off,” said Harith Ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fractyl-health-reports-q4-eps-52c-consensus-44c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fractyl-health-reports-q4-eps-52c-consensus-44c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GUTS"],"gpt_icon":0},{"id":"2516666312","title":"Fractyl Health Q4 GAAP EPS $(0.52) Misses $(0.34) Estimate, Sales $3.00K Miss $10.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666312","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666312?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:19","pubTimestamp":1741036777,"startTime":"0","endTime":"0","summary":"Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.34) by 52.94 percent. This is a 95.35 percent increase over losses of $(11.18) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44094765/fractyl-health-q4-gaap-eps-0-52-misses-0-34-estimate-sales-3-00k-miss-10-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Fractyl Health Q4 GAAP EPS $(0.52) Misses $(0.34) Estimate, Sales $3.00K Miss $10.00K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS"],"gpt_icon":1},{"id":"2516657346","title":"Fractyl Health Inc: Q4 EPS -$0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516657346?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:13","pubTimestamp":1741036381,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2516665944","title":"Press Release: Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516665944?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035900,"startTime":"0","endTime":"0","summary":"Strong patient and physician demand for pivotal REMAIN-1 study highlights urgent need for post-GLP-1 withdrawal weight maintenance solutions; midpoint data analysis anticipated in Q2 2025 and full study enrollment expected in summer 2025. Company plans to submit first Clinical Trial Application  module for RJVA-001 in type 2 diabetes to regulators in H1 2025, and if CTA is authorized, expects to report preliminary data in 2026. BURLINGTON, Mass., March 03, 2025  -- Fractyl Health, Inc.  , a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes , is redefining the future of metabolic health by tackling one of obesity care's most urgent challenges -- sustaining weight loss after GLP-1 therapy. Today, the Company announced key anticipated milestones, growing patient and physician demand for its REMAIN-1 pivotal study, and fourth quarter and full year 2024 financial results, reinforcing its momentum for continued execution","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","R","CTA","BK4082","BK4022","BK4232"],"gpt_icon":0},{"id":"2513280927","title":"Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513280927","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513280927?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"BURLINGTON, Mass., Feb. 24, 2025  -- Fractyl Health, Inc.  , a metabolic therapeutics company focused on pioneering pattern breaking approaches for the treatment of obesity and type 2 diabetes , today announced it will report financial results for the fourth quarter and full year 2024 and provide business updates on Monday, March 3, 2025, at 4:30 p.m. ET.Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com.Investor ContactBrian Luque, Head of Investor Relat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fractyl-health-report-fourth-quarter-120000200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","GUTS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GUTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"GUTS","fiscalQuarterEnding":"2024/09","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-05-13","symbol":"GUTS","fiscalQuarterEnding":"2024/03","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GUTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GUTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GUTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GUTS","date":"2025-04-17","current":-0.790483,"percent":0.975265,"low":-8.89576,"twenty":-4.567288,"median":-2.177017,"eighty":-1.373294,"high":-0.674617,"avg":-2.841795,"sd":1.715675,"marketCap":54301445},"quantilePoints":[{"date":"2024-02-09","current":-7.199681,"twenty":-7.926572,"median":-7.255064,"eighty":-7.199681,"marketCap":495114890},{"date":"2024-02-16","current":-5.558985,"twenty":-7.340906,"median":-7.07161,"eighty":-5.493911,"marketCap":382285824},{"date":"2024-02-23","current":-5.7459,"twenty":-7.221834,"median":-5.84628,"eighty":-5.558985,"marketCap":395139768},{"date":"2024-03-01","current":-6.230494,"twenty":-7.199681,"median":-5.94666,"eighty":-5.558985,"marketCap":428464809},{"date":"2024-03-08","current":-6.299721,"twenty":-7.091686,"median":-6.265108,"eighty":-5.600521,"marketCap":433225529},{"date":"2024-03-15","current":-4.67287,"twenty":-6.990614,"median":-5.94666,"eighty":-5.398377,"marketCap":321348606},{"date":"2024-03-22","current":-5.039777,"twenty":-6.954615,"median":-5.756284,"eighty":-4.992702,"marketCap":346580423},{"date":"2024-03-28","current":-4.984395,"twenty":-6.796776,"median":-5.655904,"eighty":-5.006548,"marketCap":342771847},{"date":"2024-04-05","current":-4.645542,"twenty":-6.52125,"median":-5.558985,"eighty":-4.724099,"marketCap":358129452},{"date":"2024-04-12","current":-4.260483,"twenty":-6.388333,"median":-5.351301,"eighty":-4.623184,"marketCap":328444925},{"date":"2024-04-19","current":-4.080375,"twenty":-6.308029,"median":-5.233615,"eighty":-4.529956,"marketCap":314560227},{"date":"2024-04-26","current":-4.173535,"twenty":-6.27203,"median":-5.126311,"eighty":-4.286983,"marketCap":321741967},{"date":"2024-05-03","current":-4.043112,"twenty":-6.230494,"median":-4.984395,"eighty":-4.190924,"marketCap":311687531},{"date":"2024-05-10","current":-3.863004,"twenty":-6.11696,"median":-4.746967,"eighty":-4.142482,"marketCap":297802833},{"date":"2024-05-17","current":-4.677292,"twenty":-5.874663,"median":-4.707484,"eighty":-4.142482,"marketCap":320305619},{"date":"2024-05-24","current":-5.285549,"twenty":-5.766668,"median":-4.811037,"eighty":-4.161114,"marketCap":361959713},{"date":"2024-05-31","current":-4.700095,"twenty":-5.762514,"median":-4.746967,"eighty":-4.163598,"marketCap":321867221},{"date":"2024-06-07","current":-4.52524,"twenty":-5.733439,"median":-4.74206,"eighty":-4.176019,"marketCap":309892994},{"date":"2024-06-14","current":-4.14056,"twenty":-5.683595,"median":-4.714084,"eighty":-4.173535,"marketCap":283549695},{"date":"2024-06-21","current":-3.748885,"twenty":-5.639289,"median":-4.700095,"eighty":-4.13846,"marketCap":256727426},{"date":"2024-06-28","current":-3.098426,"twenty":-5.614367,"median":-4.679113,"eighty":-4.13216,"marketCap":212183302},{"date":"2024-07-05","current":-3.126403,"twenty":-5.558985,"median":-4.67287,"eighty":-4.067954,"marketCap":214099178},{"date":"2024-07-12","current":-3.273281,"twenty":-5.558985,"median":-4.618315,"eighty":-4.043112,"marketCap":224157529},{"date":"2024-07-15","current":-3.203339,"twenty":-5.545139,"median":-4.608278,"eighty":-4.043112,"marketCap":219367838},{"date":"2024-08-02","current":-1.909414,"twenty":-5.531294,"median":-4.604496,"eighty":-3.987217,"marketCap":130758558},{"date":"2024-08-09","current":-1.272942,"twenty":-5.44822,"median":-4.571014,"eighty":-3.880394,"marketCap":87172372},{"date":"2024-08-16","current":-2.030155,"twenty":-5.362548,"median":-4.535732,"eighty":-3.763178,"marketCap":112628952},{"date":"2024-08-23","current":-2.513937,"twenty":-5.323174,"median":-4.395959,"eighty":-3.157177,"marketCap":139468192},{"date":"2024-08-30","current":-3.092747,"twenty":-5.304232,"median":-4.330871,"eighty":-3.111015,"marketCap":171579426},{"date":"2024-09-06","current":-2.833578,"twenty":-5.2807,"median":-4.287438,"eighty":-3.037457,"marketCap":157201261},{"date":"2024-09-13","current":-2.470742,"twenty":-5.255768,"median":-4.264795,"eighty":-3.016296,"marketCap":137071832},{"date":"2024-09-20","current":-2.349797,"twenty":-5.230425,"median":-4.220114,"eighty":-2.883684,"marketCap":130362022},{"date":"2024-09-27","current":-2.185656,"twenty":-5.202856,"median":-4.173535,"eighty":-2.641793,"marketCap":121255851},{"date":"2024-10-04","current":-1.995599,"twenty":-5.14085,"median":-4.150837,"eighty":-2.522576,"marketCap":110711864},{"date":"2024-10-11","current":-2.038794,"twenty":-5.128388,"median":-4.12385,"eighty":-2.410269,"marketCap":113108225},{"date":"2024-10-18","current":-2.151101,"twenty":-5.116238,"median":-4.067954,"eighty":-2.30833,"marketCap":119338762},{"date":"2024-10-25","current":-2.168379,"twenty":-5.079786,"median":-4.043112,"eighty":-2.220212,"marketCap":120297307},{"date":"2024-10-31","current":-2.894051,"twenty":-5.039777,"median":-4.043112,"eighty":-2.211573,"marketCap":160556166},{"date":"2024-11-08","current":-2.081989,"twenty":-4.998899,"median":-3.941127,"eighty":-2.185656,"marketCap":115504585},{"date":"2024-11-15","current":-1.598099,"twenty":-4.984395,"median":-3.863004,"eighty":-2.15542,"marketCap":100526792},{"date":"2024-11-22","current":-1.575159,"twenty":-4.935976,"median":-3.777242,"eighty":-2.133823,"marketCap":99083824},{"date":"2024-11-29","current":-1.95748,"twenty":-4.924867,"median":-3.755879,"eighty":-2.090628,"marketCap":123133296},{"date":"2024-12-06","current":-1.636331,"twenty":-4.88286,"median":-3.203339,"eighty":-2.064711,"marketCap":102931740},{"date":"2024-12-13","current":-1.686032,"twenty":-4.835403,"median":-3.126403,"eighty":-2.038794,"marketCap":106058171},{"date":"2024-12-20","current":-1.391646,"twenty":-4.764415,"median":-3.10542,"eighty":-1.995599,"marketCap":87540078},{"date":"2024-12-27","current":-1.575159,"twenty":-4.746556,"median":-3.092747,"eighty":-1.97958,"marketCap":99083824},{"date":"2025-01-03","current":-1.628684,"twenty":-4.743771,"median":-3.023635,"eighty":-1.95748,"marketCap":102450750},{"date":"2025-01-10","current":-1.452817,"twenty":-4.739262,"median":-3.02149,"eighty":-1.912585,"marketCap":91387993},{"date":"2025-01-17","current":-1.383999,"twenty":-4.725274,"median":-2.961882,"eighty":-1.793847,"marketCap":87059088},{"date":"2025-01-24","current":-1.567513,"twenty":-4.714084,"median":-2.915648,"eighty":-1.74338,"marketCap":98602835},{"date":"2025-01-31","current":-1.483403,"twenty":-4.707484,"median":-2.876773,"eighty":-1.674563,"marketCap":93311951},{"date":"2025-02-07","current":-1.231071,"twenty":-4.700095,"median":-2.751508,"eighty":-1.628684,"marketCap":77439299},{"date":"2025-02-14","current":-1.269303,"twenty":-4.679113,"median":-2.600327,"eighty":-1.598099,"marketCap":79844247},{"date":"2025-02-21","current":-1.116375,"twenty":-4.677656,"median":-2.557132,"eighty":-1.575159,"marketCap":70224458},{"date":"2025-02-28","current":-1.116375,"twenty":-4.673754,"median":-2.479381,"eighty":-1.574866,"marketCap":70224458},{"date":"2025-03-07","current":-1.118071,"twenty":-4.651008,"median":-2.410269,"eighty":-1.558338,"marketCap":76804746},{"date":"2025-03-14","current":-0.858137,"twenty":-4.63179,"median":-2.367075,"eighty":-1.536928,"marketCap":58948866},{"date":"2025-03-21","current":-0.875941,"twenty":-4.612293,"median":-2.315241,"eighty":-1.500225,"marketCap":60171871},{"date":"2025-03-28","current":-0.897305,"twenty":-4.602227,"median":-2.276365,"eighty":-1.465051,"marketCap":61639478},{"date":"2025-04-04","current":-0.811847,"twenty":-4.596288,"median":-2.211573,"eighty":-1.424369,"marketCap":55769051},{"date":"2025-04-11","current":-0.674617,"twenty":-4.575848,"median":-2.189976,"eighty":-1.390881,"marketCap":46342125},{"date":"2025-04-17","current":-0.790483,"twenty":-4.567288,"median":-2.177017,"eighty":-1.373294,"marketCap":54301445}],"updateTime":1745251333782}}}